CARMELL THERAPEUTICS
Carmell was founded in 2007 to commercialize technology developed jointly at Carnegie Mellon University and Allegheny General Hospital. The proprietary technology enables the manufacture of biologically-active plastics from blood plasma for treating injuries to bone and connective tissue. These plastics are sterile, off-the-shelf, easy to handle, shape and suture, have controlled degradation rates, contain known levels of bioactivity, and exhibit mechanical properties designed to match the repai... red tissue. Carmell's plastics can be simply viewed as plastic forms of ultra-concentrated blood clots; they therefore represent the ideal biomaterials, using the body's own growth and regenerative factors to naturally promote tissue healing. The Company is focused on the sports medicine market, with products designed to accelerate healing and produce better clinical outcomes in treating injuries to connective tissue (e.g., tendons, ligaments and cartilage).
CARMELL THERAPEUTICS
Industry:
Biotechnology Health Care Life Science Medical Device Therapeutics
Founded:
2007-01-01
Address:
Pittsburgh, Pennsylvania, United States
Country:
United States
Website Url:
http://www.carmellrx.com
Total Employee:
1+
Status:
Active
Contact:
4122088033
Email Addresses:
[email protected]
Total Funding:
9.04 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Font Awesome
Similar Organizations
Axcella
Axcella is a biotechnology company providing therapeutics development solutions.
Blue Belt Technologies
Blue Belt Technologies is a medical device company that focuses on technology and capabilities of surgical instrumentation.
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Spero Therapeutics
Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.
Current Advisors List
Current Employees Featured
Founder
Investors List
Innovation Works
Innovation Works investment in Seed Round - Carmell Therapeutics
Jay Yue
Jay Yue investment in Convertible Note - Carmell Therapeutics
Maine Angels
Maine Angels investment in Series B - Carmell Therapeutics
Keiretsu Forum
Keiretsu Forum investment in Series B - Carmell Therapeutics
Harbor Light Capital Partners
Harbor Light Capital Partners investment in Series B - Carmell Therapeutics
BlueTree Allied Angels
BlueTree Allied Angels investment in Series B - Carmell Therapeutics
Newlin Investment Company
Newlin Investment Company investment in Series B - Carmell Therapeutics
Pittsburgh Life Sciences Greenhouse
Pittsburgh Life Sciences Greenhouse investment in Series B - Carmell Therapeutics
Lehigh Valley Angel Investors
Lehigh Valley Angel Investors investment in Angel Round - Carmell Therapeutics
Innovation Works
Innovation Works investment in Debt Financing - Carmell Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-05-11 | Carmell Therapeutics Announces the Appointment of Sebastian “Sebby” Borriello to Chief Business Officer |
Official Site Inspections
http://www.carmellrx.com
- Host name: fwdlb.pairnic.net
- IP address: 216.92.3.120
- Location: Pittsburgh United States
- Latitude: 40.4236
- Longitude: -79.9825
- Metro Code: 508
- Timezone: America/New_York
- Postal: 15203
